Clinical Trials Arena on MSN
AiCuris reports positive Phase III pritelivir results for HSV patients
The trial enrolled and treated 101 immunocompromised patients with refractory or resistant HSV infection.
A new study in "Nature Medicine" estimates 2 million people are incorrectly told they have TB each year — and clinicians miss ...
16h
Newly obtained emails undermine RFK Jr.'s testimony about 2019 Samoa trip before measles outbreak
Documents obtained by The Guardian and The Associated Press undermine Robert F. Kennedy Jr.'s testimony during his Senate ...
Cases in fully vaccinated people are rare and usually mild, but are likely to become more common as exposure to the virus ...
Researchers examined the incidence of hepatitis B reactivation and incident infection after switching to long-acting cabotegravir plus rilpivirine among patients with HIV.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results